Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis (FIREFLY)
An Evaluation of Fluorescence Imaging + ICG Dye (Firefly) for Use in the Visual Diagnosis of Endometriosis: A Prospective Study
Sponsor: AdventHealth
Terminated
Lack of funding
Other terminated trials from AdventHealth
Other Endometriosis trials with similar outcome
Listed as NCT02038985, this NA trial focuses on Endometriosis and remains terminated or withdrawn. Sponsored by AdventHealth, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
May 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — May 2020 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated · Phase: PHASE4 → NA
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AdventHealth
For direct contact, visit the study record on ClinicalTrials.gov .